Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jun 26, 2024

BUY
$269.37 - $365.04 $0 - $0
0 New
0 $178,000
Q4 2023

Feb 15, 2024

BUY
$269.37 - $365.04 $0 - $0
0 New
0 $0
Q3 2023

Nov 15, 2023

BUY
$350.25 - $422.63 $0 - $0
0 New
0 $0
Q1 2023

May 12, 2023

BUY
$418.69 - $503.0 $200,552 - $240,937
479 New
479 $266,000
Q3 2022

Nov 03, 2022

SELL
$412.59 - $563.26 $96,546 - $131,802
-234 Reduced 15.76%
1,251 $230,000
Q2 2022

Aug 05, 2022

SELL
$463.67 - $597.16 $94,588 - $121,820
-204 Reduced 12.08%
1,485 $273,000
Q1 2022

May 13, 2022

SELL
$524.57 - $735.42 $9.03 Million - $12.7 Million
-17,211 Reduced 91.06%
1,689 $311,000
Q4 2021

Feb 11, 2022

BUY
$708.84 - $794.68 $13.4 Million - $15 Million
18,899 Added 1889900.0%
18,900 $3.31 Million
Q1 2021

May 17, 2021

SELL
$547.01 - $662.35 $1,641 - $1,987
-3 Reduced 75.0%
1 $315,000
Q4 2020

Feb 16, 2021

BUY
$510.68 - $643.45 $2,042 - $2,573
4 New
4 $2,000
Q2 2020

Aug 13, 2020

SELL
$334.87 - $493.06 $9,376 - $13,805
-28 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$320.01 - $409.07 $8,000 - $10,226
-25 Reduced 47.17%
28 $9,000
Q4 2019

Feb 28, 2020

BUY
$319.73 - $374.2 $4,476 - $5,238
14 Added 35.9%
53 $370,000
Q3 2019

Oct 15, 2019

SELL
$304.55 - $345.24 $17,054 - $19,333
-56 Reduced 58.95%
39 $13,000
Q2 2019

Jul 26, 2019

SELL
$286.93 - $312.59 $26,397 - $28,758
-92 Reduced 49.2%
95 $30,000
Q1 2019

Apr 19, 2019

BUY
$224.3 - $317.41 $41,944 - $59,355
187 New
187 $57,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.37B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Financial Gravity Asset Management, Inc. Portfolio

Follow Financial Gravity Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.